Evidence map›Paper›PMID 38985380›Full record

ArticleCEN case reports2025

A case of Fanconi syndrome that developed following a year of consumption of a red yeast rice supplement.

Yuki Kawai, Moe Ozawa, Aya Isomura, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Shohei Nagayama, Shohei Tanaka, Eriko Abe, Sanae Saka, Kiyotaka Nagahama and 2 more

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Clinical pharmacology : advances and applications · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuki Kawai *Department of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Moe Ozawa *Department of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Aya IsomuraDepartment of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Hiroshi MitsuhashiKohsaikai Yokohama Jinsei Hospital, Yokohama, Kanagawa, Japan.
Satoshi YamaguchiDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Shohei NagayamaDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Shohei TanakaDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Eriko AbeDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Sanae SakaDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Kiyotaka NagahamaDepartment of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Tamio IwamotoDepartment of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, 3-2-9 Konandai, Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan. iwamotot@nanbu.saiseikai.or.jp.ORCID 0000-0002-0265-4791
Kouichi TamuraDepartment of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although some dietary supplements have been reported to cause renal dysfunction, there have been few reports of supplement-induced Fanconi syndrome. We present the case of a 56-year-old woman with Fanconi syndrome that developed after she consumed a red yeast rice supplement. She was referred to our hospital because of renal dysfunction, and was found to have electrolyte abnormalities, including hypophosphatemia and hypouricemia, renal diabetes, and hyperchloremic metabolic acidosis, and was, therefore, diagnosed with Fanconi syndrome. Renal biopsy revealed proximal tubular injury characterized by severely degenerated tubular epithelial cells as well as mild hypocellular fibrosis. We speculated that the red yeast rice supplement, which the patient had been consuming for approximately 1 year, might be a cause of her syndrome, because reports of renal dysfunction associated with the consumption of red yeast rice supplements have emerged in Japan since 2024. After the supplement was discontinued and oral prednisolone treatment was initiated, the patient's renal function improved and her electrolyte abnormalities were ameliorated. Furthermore, even after tapering off and discontinuing the prednisolone over approximately 12 weeks, her renal function remained. Because Fanconi syndrome may be caused by various exogenous substances, the taking of a thorough medical history is crucial, including with respect to the use not only of prescription medications, but also other substances, including supplements.

Indexed as

Biological ProductsDietary SupplementsFanconi SyndromeFemaleHumansJapanKidneyMiddle AgedPrednisoloneBiological ProductsPrednisolonered yeast riceFanconi syndromePrednisoloneRed yeast riceRed yeast rice supplementSupplement

Identifiers

PMID38985380
PMCPMC11785878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.